Author

Christopher L. Baker

Observed names: C.L. Baker, Christopher Baker, Christopher L Baker

Institution: McMaster University

Observed institution: McMaster University

ORCID: 0000-0003-2019-5071

Observed ORCID: 0000-0003-2019-5071

OpenAlex ID: A5004782327

A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity

2020 · Joanne A. Hammill, Jacek M. Kwiecien, et al. · Molecular Therapy — Oncolytics · 21

Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma

2021 · Ksenia Bezverbnaya, Duane Moogk, et al. · Cytotherapy · 12

Constitutive expression of interleukin-27 diminishes proinflammatory cytokine production without impairing effector function of engineered T cells

2023 · Arya Afsahi, Rebecca Burchett, et al. · Cytotherapy · 5

T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma

2023 · Ksenia Bezverbnaya, Joanne A. Hammill, et al. · Cytotherapy · 4

DAP12-associated synthetic antigen receptors enable multi-targeting of T cells with independent chimeric receptors in a small genetic payload

2025 · Allyson E. Moore, Hayley Nault, et al. · iScience · 3

LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling

2023 · Arya Afsahi, Christopher M. Silvestri, et al. · Frontiers in Immunology · 3

HER2-specific synthetic antigen receptor T cell therapy synergizes with radiotherapy to provide improved antitumor efficacy in non-small cell lung cancer

2026 · Olga-Demetra Biziotis, Christopher M Silvestri, et al. · Journal of Leukocyte Biology · 1

Figure S7 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S3 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Table S3 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Table S2 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S10 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S2 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S13 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Table S4 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S5 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S4 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S12 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S11 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Data from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S1 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Table S1 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S9 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S6 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Figure S8 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor

2026 · Rebecca Burchett, Claire G. Morris, et al.

Works count: 29

Citation count: 49

H-index: 4

I10-index: 2